Clinical trial · Observational
Radiation Oncology Mobile Application
Radiation Oncology Mobile Application: Symptoms Reporting System and Quality Assurance Tool
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): the program couldn't be implemented
Summary
Brief summary (as posted)
To develop a novel a mobile phone application (available on Android and IOS) for patients receiving radiation treatment for head and neck cancer. Through this application, patients will get access to their treatment calender, through a system connected with Mosiac database, which provides a timely and precise access to their treatments schedule. In addition, patients will be able to report their treatment related toxicity in real time fashion, these symptoms will be addressed daily instead of the weekly floor clinic checks. Furthermore, the radiation oncologist will receive an instant notification through the application, if there is error in patient's treatment (missing field, wrong dose, etc..)
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
| Radiation Toxicity | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- head and neck radiotherapy patients
- description
- (Single arm); Patients receiving radiotherapy for head and neck cancers can report their symptoms through the mobile app.
Primary outcomes (1)
- measure
- Grade of symptoms improved with early intervention.
- timeFrame
- only during RT (7WEEKS)
- description
- using CTCAE v.5
Secondary outcomes (1)
- measure
- compliance on the mobile.
- timeFrame
- Only during RT (7WEEKS)
- description
- number of reports.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: Adult patients receiving definitive or adjuvant RT to head and neck site Chemotherapy is allowed PS:0-1 Has a smart phone Exclusion Criteria: Poor performance early laryngeal cancer Patient with metastatic disease, or palliative intent.
References
Publications (0)
Data not yet available